European Organisation for
Research and Treatment of Cancer

Active for
60+ years

Network of
3800+ members

Present in
50+ countries

100+ active
studies

20+ recruiting
studies

250+ experts
in HQ

Latest news

  • TOPGEAR trial results show no significant benefit of preoperative chemoradiotherapy on long term survival

    24 Sep 2024

  • ESMO congress 2024

    New results and forthcoming EORTC trials in prostate cancer, melanoma, head and neck, lung, rare, and breast cancers presented at ESMO 2024

    17 Sep 2024

  • EORTC-1333-GUCGPEACE III trial

    Late Breaking Results from the EORTC 1333/PEACE III phase III trial

    16 Sep 2024

Projects

SPECTA

E²-RADIATE

RECIST

Latest publications

Upcoming events

  • 36th EORTC-NCI-AACR Symposium - Banner

    36th EORTC-NCI-AACR Symposium

    23 Oct - 25 Oct 2024

    Barcelona, Spain

  • Cutaneous Lymphoma Tumours Group

    EORTC Cutaneous Lymphoma Tumour Group Annual Meeting 2024

    09 Oct - 11 Oct 2024

    Lausanne, Switzerland

    • Past events

  • Clinical Trial Statistics for Non-Statisticians

    Clinical Trial Statistics for Non-Statisticians

    11 Jun - 14 Jun 2024

    Brussels, BE

  • Cancer Medicines Forum - Workshop

    Cancer Medicines Forum workshop

    05 Apr - 05 Apr 2024

    Amsterdam, NL (Hybrid Event)

    • Highlights

    • EORTC Annual Report 2023

      Publication of 2023 EORTC Annual Report

    • Manifesto - Illustration

      Manifesto

    • EORTC Practice Changing Trials

      Practice Changing Trials

    • EORTC Cancer Research Fund

      ECRF

      EORTC Cancer Research Fund